bioAffinity Technologies, Inc. (BIAF) vs T2 Biosystems, Inc. (TTOO)
- bioAffinity Technologies, Inc. BIAF 3.73 −5.81%
- T2 Biosystems, Inc. TTOO 0.00 NaN
bioAffinity Technologies, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $5.1M — 1.3× the size. bioAffinity Technologies, Inc. grew revenue faster over the last twelve months: −23.2% against −30.2%. bioAffinity Technologies, Inc. has the higher net margin (−257.3% vs −559.5%) and the lower return on invested capital (−408.7% vs 0.00%). Across the 15 metrics below, T2 Biosystems, Inc. leads on 8 and bioAffinity Technologies, Inc. on 7.
Valuation
Profitability
| Metric | BIAF | TTOO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 34.61% | (76.76%) | 50.89% |
| Operating margin | (209.82%) | (542.59%) | (8.57%) |
| Net margin | (257.33%) | (559.52%) | (6.37%) |
| Free cash flow margin | (195.90%) | (476.64%) | 0.00% |
| Return on equity | (1,860.15%) | 277.61% | (2.92%) |
| Return on assets | (245.51%) | (140.00%) | (6.71%) |
| Return on invested capital | (408.67%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack